SG10201913687VA - Generation of midbrain-specific organoids from human pluripotent stem cells - Google Patents

Generation of midbrain-specific organoids from human pluripotent stem cells

Info

Publication number
SG10201913687VA
SG10201913687VA SG10201913687VA SG10201913687VA SG10201913687VA SG 10201913687V A SG10201913687V A SG 10201913687VA SG 10201913687V A SG10201913687V A SG 10201913687VA SG 10201913687V A SG10201913687V A SG 10201913687VA SG 10201913687V A SG10201913687V A SG 10201913687VA
Authority
SG
Singapore
Prior art keywords
midbrain
generation
stem cells
pluripotent stem
human pluripotent
Prior art date
Application number
SG10201913687VA
Other languages
English (en)
Inventor
Junghyun Jo
Huck Hui Ng
Hyunsoo Shawn Je
Original Assignee
Agency Science Tech & Res
Nat Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res, Nat Univ Singapore filed Critical Agency Science Tech & Res
Publication of SG10201913687VA publication Critical patent/SG10201913687VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/41—Hedgehog proteins; Cyclopamine (inhibitor)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/72—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/78—Cellulose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Developmental Biology & Embryology (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG10201913687VA 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells SG10201913687VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201601965P 2016-03-14

Publications (1)

Publication Number Publication Date
SG10201913687VA true SG10201913687VA (en) 2020-03-30

Family

ID=59851957

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201807487WA SG11201807487WA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells
SG10201913687VA SG10201913687VA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201807487WA SG11201807487WA (en) 2016-03-14 2017-03-14 Generation of midbrain-specific organoids from human pluripotent stem cells

Country Status (5)

Country Link
US (1) US20190169576A1 (fr)
EP (1) EP3430132A4 (fr)
CN (1) CN109996870B (fr)
SG (2) SG11201807487WA (fr)
WO (1) WO2017160234A1 (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140441A2 (fr) 2010-05-06 2011-11-10 Children's Hospital Medical Center Procédés et systèmes de conversion de cellules précurseurs en tissus intestinaux par différenciation dirigée
CN113249297A (zh) 2014-05-28 2021-08-13 儿童医院医疗中心 用于经由定向分化将前体细胞转化为胃组织的方法和系统
US11584916B2 (en) 2014-10-17 2023-02-21 Children's Hospital Medical Center Method of making in vivo human small intestine organoids from pluripotent stem cells
EP3452578B1 (fr) 2016-05-05 2022-08-10 Children's Hospital Medical Center Procédés de fabrication in vitro de tissu de fundus d'estomac et compositions associées à celui-ci
US10583286B2 (en) * 2016-08-23 2020-03-10 Boston Scientific Neuromodulation Corporation Methods and devices for neuromodulation of the adrenal gland
NZ753873A (en) 2016-12-05 2023-01-27 Children’S Hospital Medical Center Colonic organoids and methods of making and using same
CN108456659B (zh) * 2018-03-14 2020-05-05 浙江霍德生物工程有限公司 3d大脑类器官的制备方法
CN110295145B (zh) * 2018-03-22 2020-10-16 苏州麦迪耐斯医药科技有限公司 一种体外培养脑肿瘤细胞的培养液及培养方法
US20220049219A1 (en) * 2018-09-11 2022-02-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Automated generation and analysis of organoids
WO2020100481A1 (fr) * 2018-11-15 2020-05-22 Jsr株式会社 Procédé de production d'organoïdes cérébraux
EP3924468A1 (fr) * 2019-02-11 2021-12-22 Miltenyi Biotec B.V. & Co. KG Génération de structures de tissu artificiel dérivées de cellules souches pluripotentes humaines sans matrices tridimensionnelles
JP7366332B2 (ja) * 2019-06-05 2023-10-23 公立大学法人奈良県立医科大学 脳幹オルガノイドの作製方法
EP4001401A4 (fr) * 2019-07-05 2023-07-19 Keio University Procédé de fabrication d'organoïde cérébral
KR102228400B1 (ko) * 2019-09-24 2021-03-16 고려대학교 산학협력단 뇌 오가노이드 제조 방법
JP2023503302A (ja) * 2019-11-22 2023-01-27 ノヴォ ノルディスク アー／エス スピン凝集した神経系マイクロスフェアおよびその応用
WO2021146349A1 (fr) * 2020-01-13 2021-07-22 Aspen Neuroscience, Inc. Procédé de différenciation de cellules nerveuses et compositions associées et méthodes d'utilisation
US20230165909A1 (en) * 2020-04-21 2023-06-01 Aspen Neuroscience, Inc. Gene editing of lrrk2 in stem cells and method of use of cells differentiated therefrom
WO2021216622A1 (fr) * 2020-04-21 2021-10-28 Aspen Neuroscience, Inc. Édition génique de gba1 dans des cellules souches et procédé d'utilisation de cellules différenciées à partir de celles-ci
WO2021232234A1 (fr) * 2020-05-19 2021-11-25 武汉睿健医药科技有限公司 Procédé d'induction sans sérum pour cellule neuronale sensorielle
US20230323292A1 (en) * 2020-06-08 2023-10-12 Technische Universiteit Eindhoven Methods for producing a (three dimensional) neural tissue
CN115885037A (zh) * 2020-06-29 2023-03-31 广东省奥干诺伊德生物科技有限公司 中脑类器官及其高速大规模制造方法、利用它筛选神经毒性物质和筛选多巴胺能神经元相关疾病药物的方法
KR102346243B1 (ko) * 2020-06-29 2022-01-04 주식회사 오간팩토리 중뇌 오가노이드, 이의 고속 및 대량 제조 방법, 이를 이용한 신경독성물질 스크리닝 방법 및 도파민성 신경세포 관련 질환 치료제 스크리닝 방법
EP3992280A1 (fr) * 2020-10-30 2022-05-04 Kugelmeiers Ltd. Procédé de génération de neurosphères
CN114736864B (zh) * 2020-12-23 2024-01-26 武汉睿健医药科技有限公司 一种神经干细胞诱导分化培养基及诱导分化方法
CN113046309B (zh) * 2021-03-26 2023-05-05 成都云测医学生物技术有限公司 悬浮培养脑类器官的培养基及其应用
CN113249319B (zh) * 2021-05-19 2022-11-11 北京大学 一种脑脊液类器官的培养基及其培养方法
CN113789301B (zh) * 2021-08-27 2022-05-10 广州瑞臻再生医学科技有限公司 一种制备高纯度的诱导性多能干细胞来源的人脑多巴胺能神经元的方法
CN113493768B (zh) * 2021-09-06 2021-12-24 中国科学院动物研究所 神经类器官及其制备方法
KR20230081737A (ko) * 2021-11-29 2023-06-08 주식회사 오간팩토리 간 오가노이드, 이의 고속 및 대량 제조 방법, 이를 이용한 약물의 효능 및 독성 스크리닝 방법
WO2023137200A2 (fr) * 2022-01-13 2023-07-20 The Board Of Trustees Of The Leland Stanford Junior University Génération d'organoïdes d'organisateur neuronal et d'assembloïdes de ligne médiane à partir de cellules souches pluripotentes humaines
CN115404218B (zh) * 2022-01-13 2024-09-24 南华大学附属第一医院 一种包含胶质细胞的3d人脑类器官培养方法
CN115851575A (zh) * 2022-01-17 2023-03-28 滨州医学院 一种胃类器官培养的培养基及其应用
WO2023201046A1 (fr) * 2022-04-14 2023-10-19 Lieber Institute, Inc. Compositions et méthode de traitement d'une dystonie-parkinsonisme liée à l'x
EP4286513A1 (fr) 2022-06-03 2023-12-06 IMBA-Institut für Molekulare Biotechnologie GmbH Fusion de culture de tissus triple
WO2024017538A1 (fr) * 2022-07-19 2024-01-25 Medizinische Hochschule Hannover Procédé de production d'organoïdes à partir de cellules de mammifère
EP4310177A1 (fr) * 2022-07-19 2024-01-24 Medizinische Hochschule Hannover Procédé de production d'organoïdes à partir de cellules de mammifères
CN115044539A (zh) * 2022-08-16 2022-09-13 中义(北京)健康研究院 一种鲨鱼肝细胞及其培养方法
WO2024113351A1 (fr) * 2022-12-02 2024-06-06 Nuwacell Biotechnologies Co., Ltd. Milieu de culture, matrice de revêtement et procédé de maturation de cellules progénitrices dopaminergiques du mésencéphale
CN117778313B (zh) * 2024-02-23 2024-05-24 成都云测医学生物技术有限公司 脑类器官获得间充质干细胞分化方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111244D0 (en) * 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
AU2013251749B2 (en) * 2012-04-24 2019-01-17 International Stem Cell Corporation Derivation of neural stem cells and dopaminergic neurons from human pluripotent stem cells
EP2743345A1 (fr) * 2012-12-13 2014-06-18 IMBA-Institut für Molekulare Biotechnologie GmbH Culture de tissu différencié hétérogène tridimensionnel
KR101696874B1 (ko) * 2013-07-31 2017-01-16 한국생명공학연구원 직접 리프로그래밍을 통한 유도 도파민성 전구세포 제조방법
DE102014003465A1 (de) * 2014-03-11 2015-09-17 NeuroProof GmbH Gewinnung von Gehirnregion-spezifischen neuronalen Kulturen aus dreidimensionalen Gewebekulturen von Stammzellen
JP6718431B2 (ja) * 2014-03-21 2020-07-08 フジフィルム セルラー ダイナミクス，インコーポレイテッド 中脳ドーパミン作動性ニューロンの生産およびその使用方法
EP3265104A4 (fr) * 2015-03-03 2018-11-07 President and Fellows of Harvard College Procédés de génération de tissu humain fonctionnel
LU92845B1 (en) * 2015-10-08 2017-05-02 Univ Du Luxembourg Campus Belval Means and methods for generating midbrain organoids
EP3190176A1 (fr) * 2016-01-11 2017-07-12 IMBA-Institut für Molekulare Biotechnologie GmbH Procédé de développement de culture tissulaire sur échafaudage et culture de tissus différenciés

Also Published As

Publication number Publication date
EP3430132A1 (fr) 2019-01-23
WO2017160234A1 (fr) 2017-09-21
US20190169576A1 (en) 2019-06-06
SG11201807487WA (en) 2018-09-27
CN109996870A (zh) 2019-07-09
EP3430132A4 (fr) 2019-12-25
CN109996870B (zh) 2024-08-13

Similar Documents

Publication Publication Date Title
SG10201913687VA (en) Generation of midbrain-specific organoids from human pluripotent stem cells
SG11201803043VA (en) Derivation of human skin organoids from pluripotent stem cells
EP3350313A4 (fr) Dérivation d'organoïdes hépatiques à partir de cellules souches pluripotentes humaines
SG11201708359TA (en) Generation of functional cells from stem cells
HK1246342A1 (zh) 產生源自幹細胞的β細胞的方法及其用途
EP3420073C0 (fr) Génération de cellules bêta fonctionnelles de cellules souches pluripotentes humaines à partir de cellules progénitrices endocrines
EP3334820C0 (fr) Cellules souches pluripotentes étendues et induites, procédés de fabrication et d'utilisation
PL3145517T3 (pl) Funkcjonalne oligodendrocyty pochodzące z pluripotencjalnych komórek macierzystych oraz sposoby ich otrzymywania i stosowania
IL241930B (en) Isolated naive pluripotent stem cells and methods of generating same
SG11201705695QA (en) Differentiation of macrophages from pluripotent stem cells
IL245759A (en) Characterization of the origin of a functional cranial placode from human pluripotent stem cells
GB201709599D0 (en) Methods for generation of podocytes from pluripotent stem cells and cells produced by the same
ZA201704868B (en) Suspension culturing of pluripotent stem cells
EP3188667A4 (fr) Analyse et génération de gènes de procédés à base de cellules souches et appareil
IL260824A (en) Differentiation of human pluripotent stem cells into cortical neurons
EP3286301A4 (fr) Génération de cellules de lignées musculaires à partir de cellules souches
PT3551748T (pt) Células estaminais do mesênquima derivadas de tecido perinatal: método de preparação e suas utilizações
IL267012A (en) New picolinic acid histories and their use as intermediates
IL263265A (en) Use of mesenchymal stem cells and their parts
EP3290512C0 (fr) Procédé de détermination de la pureté de cellules souches mésenchymateuses isolés de cordon ombilical
EP2961277A4 (fr) Utilisation de neurones issus de céllules souches pluripotentes humaines pour le traitement de maladies neurodégénératives
PL3136878T3 (pl) Preparaty ze skupisk ścian komórkowych roślinnej tkanki miękiszowej
DK3158057T3 (da) Stamcelleterapi ved endometriepatologier
EP3383182C0 (fr) Procédés de production de cellules souches hématopoïétiques fonctionnelles
EP3872164C0 (fr) Isolation de cellules souches du tissu adipeux